Schrodinger's shares have declined sharply in recent weeks, due largely to soft guidance for the fourth quarter. There is little reason to believe that this is anything more than a temporary headwind ...

Schrodinger's stock has performed well this year due to AI hype and strength in its drug discovery business. While the company appears attractively valued from a long-term perspective, the tight ...

NEWARK, NEW JERSEY, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Schrodinger, an ERC-20 memecoin, was launched on September 21st. It saw an incredible price growth of 22,000% in just 24 hours as a tribute to ...

The candidate is so far away that it might even break our models of the early universe. But there's a catch. Jackson Ryan was CNET's science editor, and a multiple award-winning one at that. Earlier, ...

Schrodinger (SDGR) today announced a research collaboration and license agreement with Novartis (NVS) to advance multiple development candidates into Novartis’s portfolio for further development. The ...

Schrodinger, Inc. (NASDAQ:SDGR), a pharmaceutical preparations company with a market capitalization of $1.4 billion, has reached a settlement in a lawsuit regarding its non-employee director ...